发明名称 Quinoline and quinazoline compounds useful in therapy
摘要 <p>Compounds of formula I, &lt;CHEM&gt; wherein R&lt;1&gt; represents C1-4 alkoxy optionally substituted by one or more fluorine atoms, R&lt;2&gt; represents an aryl group or a heteroaryl group, optionally substituted by C1-4 alkyl or SO2NH2; R&lt;3&gt; represents a 4-, 5-, 6-, or 7-membered heterocyclic ring containing at least one heteroatom selected from N, O and S, the ring being optionally fused to a benzene ring or a 5- or 6-membered heterocyclic ring containing at least one heteroatom selected from N, O and S, the ring system as a whole being optionally substituted, X represents CH or N; and L is absent, or represents a cyclic group of formula Ia, &lt;CHEM&gt; or represents a chain of formula Ib, &lt;CHEM&gt; and pharmaceutically acceptable salts thereof, are useful in the treatment of a variety of disorders including benign prostatic hyperplasia.</p>
申请公布号 EP0875506(A1) 申请公布日期 1998.11.04
申请号 EP19980302968 申请日期 1998.04.16
申请人 PFIZER LIMITED;PFIZER INC. 发明人 COLLIS, ALAN JOHN;FOX, DAVID NATHAN ABRAHAM
分类号 C07D239/94;A61K31/47;A61K31/4706;A61K31/505;A61K31/517;A61K31/535;A61K31/5355;A61K31/55;A61K31/551;A61P13/02;A61P13/08;A61P15/00;C07C255/61;C07D215/42;C07D239/95;C07D401/04;C07D401/12;C07D401/14;C07D403/04;C07D405/12;C07D405/14;C07D471/04;(IPC1-7):C07D215/42 主分类号 C07D239/94
代理机构 代理人
主权项
地址